IP Library Granted Patent US 7,623,926
Granted Patent B2
US 7,623,926 · App. 10/818,738 · Granted Nov 24, 2009

Stimulus regimens for cardiovascular reflex control

Assignee: CVRx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,623,926
App. No.
10/818,738
Granted
Nov 24, 2009
Kind
B2
Abstract

Baroreflex activation is achieved by providing suitable control signals to a baroreflex activation device. A method comprises establishing a therapy interval (possibly on the order of minutes to hours, or possibly of indefinite duration), within the therapy interval, establishing a plurality of dose intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of at least some dose intervals. Another method comprises establishing a series of therapy interval portions, during at least some therapy intervals, establishing a plurality of burst intervals (perhaps having durations commensurate with an interval between heartbeats), and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of the therapy intervals and also differs between first and second portions of at least some burst intervals.

Claims (28)

1. A method of controlling a baroreflex activation device for the treatment of hypertension, the method comprising:

implanting the baroreflex activation device on or within a blood vessel proximate one or more baroreceptors, the baroreflex activation device including at least one electrode configured to deliver therapy to the one or more baroreceptors based on a control signal;

providing a controller coupled to the baroreflex activation device; and

using the controller to generate the control signal based on a therapy interval defined by a plurality of burst intervals each defined by a series of electrical pulses and including a first burst portion and a second burst portion each having a burst average power defined by a number of electrical pulses delivered over a period less than or equal to that burst portion, wherein the therapy interval includes a first therapy portion and a second therapy portion each having a therapy average power defined by a number of electrical pulses delivered over a period at least equal to a plurality of burst intervals, wherein the burst average power of the first burst portion is different than the burst average power of the second burst portion and wherein the therapy average power of the first therapy portion is different than the therapy average power of the second therapy portion.

2. The method of claim 1 , wherein the first therapy portion is at least partly characterized by an initial increase in the therapy average power followed by a generally constant therapy average power followed by a decrease in therapy average power.

3. The method of claim 1 , wherein each electrical pulse in the series of electrical pulses is substantially identical.

4. The method of claim 3 , wherein each electrical pulse has identical pulse amplitudes and identical pulse widths.

5. The method of claim 1 , wherein the burst average power of the first burst portion is greater than the burst average power of the second burst portion and wherein the therapy average power of the first therapy portion is greater than the therapy average power of the second therapy portion.

6. The method of claim 1 , wherein the therapy interval is further defined by a plurality of dose intervals, each dose interval defined by a plurality of burst intervals and each dose interval having a first dose portion and a second dose portion each having a dose average power defined by a number of electrical pulses delivered over a period less than or equal to that dose portion, and wherein the therapy average power is further defined by a number of electrical pulses delivered over a period at least equal to a plurality of dose intervals.

7. The method of claim 6 , wherein the first dose portion is at least partly characterized by an initial increase in the dose average power followed by a generally constant dose average power followed by a decrease in dose average power.

8. The method of claim 6 wherein any of the therapy interval, dose interval, or burst interval are triggered by a signal having a correlation with a physiologic response that is characterized by a time interval longer than a cardiac cycle.

9. The method of claim 8 wherein the physiologic response is respiration.

10. The method of claim 8 wherein the physiologic response is one or more of inspiration and expiration.

11. The method of claim 6 wherein the therapy interval is further defined by a variation in average power over a plurality of dose intervals.

12. The method of claim 1 wherein the therapy interval is on the order of minutes to hours.

13. The method of claim 1 wherein the therapy interval is of an indefinite duration.

14. The method of claim 1 , wherein the burst interval is on the order of a cardiac cycle.

15. The method of claim 1 , wherein the second therapy portion average power is zero.

16. The method of claim 1 , wherein the baroreflex activation device includes a second electrode configured to deliver therapy to the one or more baroreceptors based on the control signal, the method further comprising interleaving the control signal between the first electrode and the second electrode.

17. The method of claim 16 , further comprising interleaving the control signal between the first electrode and the second electrode at the individual pulse level.

18. The method of claim 16 , further comprising interleaving the control signal between the first electrode and the second electrode at the burst level.

19. The method of claim 16 , further comprising interleaving the control signal between the first electrode and the second electrode at the therapy level.

20. A method, comprising:

providing a baroreflex activation device including at least one electrode configured to deliver therapy to one or more baroreceptors based on a control signal;

providing a controller coupled to the baroreflex activation device; and

providing instructions for controlling the baroreflex activation device for the treatment of hypertension, the instructions comprising:

implanting the baroreflex activation device on or within a blood vessel proximate one or more baroreceptors;

generating the control signal with the controller based on a therapy interval defined by a plurality of burst intervals each defined by a series of electrical pulses and including a first burst portion and a second burst portion each having a burst average power defined by a number of electrical pulses delivered over a period less than or equal to that burst portion, wherein the therapy interval includes a first therapy portion and a second therapy portion each having a therapy average power defined by a number of electrical pulses delivered over a period at least equal to a plurality of burst intervals, wherein the burst average power of the first burst portion is different than the burst average power of the second burst portion and wherein the therapy average power of the first therapy portion is different than the therapy average power of the second therapy portion.

Assignments (3)
SECURITY INTEREST Recorded Oct 31, 2022
From: CVRX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 061824/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2007
From: ROSSING, MARTIN A.; KIEVAL, ROBERT S.; SERDAR, DAVID J.; PERSSON, BRUCE J.
To: CVRX, INC.
Reel/Frame 019201/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2004
From: ROSSING, MARTIN A.
To: CVRX, INC.
Reel/Frame 015680/0891 →
Continuity (4)
Continuation In Part 0996407900 · Sep 26, 2001
Continuation In Part 0996377700 · Sep 26, 2001
Continuation In Part 0996399100 · Sep 26, 2001
Related Publication 20040254616A1 · Dec 16, 2004